Page 336

Dolby JM, Thow DCW, and Standfast AFB. 1961. The intranasal infection of mice with Bordetella pertussis. Journal of Hygiene 59:191-216.

Gillenius P, Jaatmaa E, Askelof P, Granstrom M, Tiru M. 1985. The standardization of an assay for pertussis toxin and antitoxin in microplate culture of Chinese hamster ovary cells. Journal of Biological Standardization 13:61-66.

Hewlett EL, Sauer KT, Myers GA, Cowell JL, Guerrant RL. 1983. Induction of a novel morphological response in Chinese hamster ovary cells by pertussis toxin. Infection and Immunity 40:1198-1203.

Kendrick PL, Eldering G, Dixon MK, Misner J. 1947. Mouse protection tests in the study of pertussis vaccine. American Journal of Public Health 37:803-810.

Kendrick PL, Updyke EL, Eldering G. 1949. Comparison of pertussis cultures by mouse protection and virulence tests. American Journal of Public Health 39:179-184.

Manclark CR, Hansen CT, Treadwell PE, Pittman M. 1976. Selective breeding to establish a standard mouse for pertussis vaccine bioassay. 2. Bioresponses of mice susceptible and resistant to sensitisation by pertussis vaccine HSF. Journal of Biological Standardardization 3:353-363.

Medical Research Council. 1959. Vaccination against whooping cough: the final report. British Medical Journal 1:994-1000.

Musser JM, Hewlett EL, Peppler MS, Selander RK. 1986. Genetic diversity and relationships in populations of Bordetella spp. Journal of Bacteriology 166:230-237.

Pittman M. 1970. Bordetella pertussis—bacterial and host factors in the pathogenesis and prevention of whooping cough. In: Mudd S, ed. Infectious Agents and Host Reactions. Philadelphia: W.B. Saunders Co.

Pittman M, Furman BL, Wardlaw AC. 1980. Bordetella pertussis respiratory tract infection in the mouse: pathophysiological response. Journal of Infectious Diseases 142:56-66.

Proom H. 1947. The immunological aspects of experimental Haemophilus pertussis infection. Journal of Pathology and Bacteriology 59:165-180.

Sato Y, Sato H. 1988. Animal models of pertussis. In: Wardlaw AC, Parton R, eds. Pathogenesis and Immunity in Pertussis. New York: John Wiley & Sons.

Sato Y, Izumiya K, Sato H, Cowell JL, Manclark CR. 1981. Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis. Infection and Immunity 31:1223-1231.

Shahin RD, Brennan MJ, Li ZM, Meade BD, Manclark CR. 1990. Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis. Journal of Experimental Medicine 171:63-73.

Standfast AFB. 1958. The comparison between field trials and mouse protection tests against intranasal and intracerebral challenges with Bordetella pertussis. Immunology 2:135-143.

Weiss AA, Hewlett EL. 1986. Virulence factors of Bordetella pertussis. Annual Review of Microbiology 40:661-686.

Weiss AA, Hewlett EL, Myers GA, Falkow S. 1983. Tn5-induced mutations affecting virulence factors of Bordetella pertussis. Infection and Immunity 42:33-41.

Weiss AA, Hewlett EL, Myers GA, Falkow S. 1984. Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors in Bordetella pertussis. Journal of Infectious Diseases 150:219-222.

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement